Pharmacokinetic/Pharmacodynamic Modeling to Support A Lack of Effect of Tafenoquine (TQ) on the QT Interval in a Thorough QT (TQT) Study

被引：0
|
作者：
Patel, Bela [1 ]
Miller, Ann [1 ]
Tenero, David [1 ]
Green, Justin [2 ]
机构：
[1] GlaxoSmithKline, Clin Pharmacol Modeling & Simulat, King Of Prussia, PA USA
[2] GlaxoSmithKline, Dis Dev World, Clin Dev, Stevenage, Herts, England
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-003
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [21] SUBJECTS IN A POSITIVE THOROUGH QT STUDY RESPOND SIMILARLY TO MOXIFLOXACIN AND TWO DOSES OF STUDY DRUG: IS THIS A PHARMACOKINETIC OR A PHARMACODYNAMIC RESPONSE?
    Panicker, G. K.
    Kerkar, V
    Natekar, M.
    Karnad, D. R.
    Kothari, S.
    Narula, O.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1112 - 1112
  • [22] Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation
    Kim, Yun
    Kim, Anhye
    Chung, Jae-Yong
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 285 : 120 - 126
  • [23] PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QT
    Henrich, Andrea
    Juif, Pierre-Eric
    Dingemanse, Jasper
    Krause, Andreas
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2021, 48 (02) : 213 - 224
  • [24] PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QT
    Andrea Henrich
    Pierre-Eric Juif
    Jasper Dingemanse
    Andreas Krause
    Journal of Pharmacokinetics and Pharmacodynamics, 2021, 48 : 213 - 224
  • [25] Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses
    Friberg, LE
    Isbister, GK
    Duffull, SB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (02) : 177 - 190
  • [26] Lack of significant effect of bilastine on ventricular repolarization. A thorough QT/QTc study
    Sologuren, A.
    Valiente, R.
    Allison, M.
    Tyl, B.
    ALLERGY, 2008, 63 : 85 - 85
  • [27] Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study
    Hulhoven, Reginald
    Rosillon, Dominique
    Letiexhe, Michel
    Meeus, Marie-Anne
    Daoust, Agnes
    Stockis, Armel
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) : 1011 - 1017
  • [28] Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study
    Jan de Jong
    Peter Hellemans
    James Juhui Jiao
    Yuhan Huang
    Sofie Mesens
    Juthamas Sukbuntherng
    Daniele Ouellet
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 1227 - 1237
  • [29] Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study
    de Jong, Jan
    Hellemans, Peter
    Jiao, James Juhui
    Huang, Yuhan
    Mesens, Sofie
    Sukbuntherng, Juthamas
    Ouellet, Daniele
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (06) : 1227 - 1237
  • [30] Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study
    Réginald Hulhoven
    Dominique Rosillon
    Michel Letiexhe
    Marie-Anne Meeus
    Agnès Daoust
    Armel Stockis
    European Journal of Clinical Pharmacology, 2007, 63 : 1011 - 1017
12345